Scarica l'app Stockscreener
0.788
2.18%
0.0168
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.7712
Aprire:
$0.78
Volume 24 ore:
558.37K
Relative Volume:
0.52
Capitalizzazione di mercato:
$101.79M
Reddito:
-
Utile/perdita netta:
$-26.91M
Rapporto P/E:
-3.5818
EPS:
-0.22
Flusso di cassa netto:
$-19.57M
1 W Prestazione:
+3.29%
1M Prestazione:
-2.11%
6M Prestazione:
+6.01%
1 anno Prestazione:
-42.06%
Intervallo 1D:
$0.7701
$0.798
Intervallo di 1 settimana:
$0.75
$0.798
Portata 52W:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Nome
Atossa Therapeutics Inc
Settore
Industria
Telefono
206.588.0256
Indirizzo
10202 5TH AVENUE NE, SEATTLE, WA
Confronta ATOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.788 | 99.62M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-01-26 | Iniziato | Maxim Group | Buy |
Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie
What to expect from Atossa Therapeutics Inc. in the next 30 daysJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
Custom watchlist performance reports with Atossa Therapeutics Inc.July 2025 Pullbacks & Low Drawdown Momentum Ideas - Newser
Forecasting Atossa Therapeutics Inc. price range with options dataQuarterly Market Summary & AI Enhanced Execution Alerts - Newser
Can technical indicators confirm Atossa Therapeutics Inc.’s reversal - Newser
What recovery options are there for Atossa Therapeutics Inc.Market Sentiment Summary & Daily Chart Pattern Signal Reports - Newser
Using data models to predict Atossa Therapeutics Inc. stock movementWeekly Trend Recap & Daily Profit Maximizing Trade Tips - Newser
Is Atossa Therapeutics Inc. stock influenced by commodity pricesJuly 2025 EndofMonth & Verified Swing Trading Watchlist - خودرو بانک
Full technical analysis of Atossa Therapeutics Inc. stock2025 Volume Leaders & Long-Term Capital Growth Ideas - Newser
Market reaction to Atossa Therapeutics Inc.’s recent newsAnalyst Downgrade & Daily Price Action Insights - Newser
Does Atossa Therapeutics Inc. align with a passive investing strategyEarnings Miss & AI Powered Buy and Sell Recommendations - خودرو بانک
Charles Schwab Investment Management Inc. Grows Stake in Atossa Genetics Inc. $ATOS - Defense World
Weekly Earnings: Is Atossa Therapeutics Inc. undervalued by DCF analysisMarket Growth Summary & Safe Capital Allocation Plans - خودرو بانک
Does Atossa Therapeutics Inc. show high probability of rebound2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Does Atossa Therapeutics Inc. have high return on assets2025 Technical Overview & AI Powered Trade Plan Recommendations - خودرو بانک
How cyclical is Atossa Therapeutics Inc.’s revenue streamJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک
Is Atossa Therapeutics Inc. building a consolidation base2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Multi factor analysis applied to Atossa Therapeutics Inc.July 2025 Outlook & Short-Term Trading Alerts - Newser
Can momentum traders help lift Atossa Therapeutics Inc.Weekly Market Report & AI Optimized Trade Strategies - Newser
Has Atossa Therapeutics Inc. found a price floor2025 Earnings Impact & Technical Entry and Exit Tips - Newser
Detecting support and resistance levels for Atossa Therapeutics Inc.July 2025 Setups & Risk Managed Investment Signals - Newser
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The News-Press
What technical models suggest about Atossa Therapeutics Inc.’s comebackJuly 2025 PreEarnings & Stepwise Trade Execution Plans - Newser
Using RSI to spot recovery in Atossa Therapeutics Inc.July 2025 Levels & AI Based Buy and Sell Signals - Newser
Real time social sentiment graph for Atossa Therapeutics Inc.Market Trend Review & Stepwise Trade Signal Implementation - Newser
What to do if you’re stuck in Atossa Therapeutics Inc.2025 Price Momentum & Expert Approved Trade Ideas - Newser
Analyzing drawdowns of Atossa Therapeutics Inc. with statistical toolsMarket Volume Summary & Real-Time Volume Triggers - Newser
How to track smart money flows in Atossa Therapeutics Inc.Earnings Growth Report & Risk Controlled Daily Plans - Newser
Measuring Atossa Therapeutics Inc.’s beta against major indicesEarnings Beat & Technical Buy Zone Confirmation - Newser
Is Atossa Therapeutics Inc. stock showing strong momentum2025 Historical Comparison & Expert Curated Trade Setups - خودرو بانک
Will Atossa Therapeutics Inc. stock go up soonQuarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
Leading vs lagging indicators on Atossa Therapeutics Inc. performanceJuly 2025 Action & Daily Growth Stock Investment Tips - Newser
Atossa Therapeutics' Cash Burn: A Closer Look - AInvest
We're Hopeful That Atossa Therapeutics (NASDAQ:ATOS) Will Use Its Cash Wisely - Yahoo Finance
Does Atossa Therapeutics Inc. have a competitive edgeJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - خودرو بانک
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Florida Times-Union
Statistical indicators supporting Atossa Therapeutics Inc.’s strength2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Top chart patterns to watch in Atossa Therapeutics Inc.July 2025 Price Swings & Weekly Breakout Stock Alerts - Newser
Is Atossa Therapeutics Inc. undervalued by DCF analysisJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Does Atossa Therapeutics Inc. have strong EBITDA marginsWeekly Stock Analysis & Risk Controlled Stock Alerts - خودرو بانک
Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):